| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.002 | 1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |